ClinicalTrials.Veeva

Menu

Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects

Yale University logo

Yale University

Status and phase

Completed
Phase 1

Conditions

Healthy Subjects

Treatments

Drug: Nicotine
Drug: Placebo
Drug: Ketamine
Drug: Ketamine and Nicotine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study examines the interactive effects of ketamine and nicotine.

Enrollment

30 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • 18-50 years old
  • Smokers

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

30 participants in 4 patient groups, including a placebo group

Ketamine and Nicotine
Active Comparator group
Description:
* 0.23 mg/kg of ketamine bolus IV (in the arm) over one minute followed by maintenance infusion at 0.58mg/kg/hour x 30 minutes, followed by 0.29 mg/kg/hour x 64 minutes. * 13.5 µg/kg of nicotine IV (in the arm) given over 10 min (1.35 µg/min/kg), followed by a constant infusion of 31.02 µg/kg given over 85 min (0.365 µg/min/kg)
Treatment:
Drug: Ketamine and Nicotine
Placebo Comparator
Placebo Comparator group
Description:
-Placebo administration: Normal saline (sodium chloride 0.9%)over 95 minutes
Treatment:
Drug: Placebo
Ketamine and Placebo
Active Comparator group
Description:
Ketamine administration: 0.23 mg/kg bolus over one minute followed by maintenance infusion at 0.58mg/kg/hour x 30 minutes, followed by 0.29 mg/kg/hour x 64 minutes Placebo administration: Normal saline (sodium chloride 0.9%)over 94 minutes
Treatment:
Drug: Ketamine
Nicotine and Placebo
Active Comparator group
Description:
Nicotine: 13.5 µg/kg given over 10 min (1.35 µg/min/kg)IV (in the arm), followed by a constant infusion of 31.02 µg/kg given over 85 min (0.365 µg/min/kg) Placebo: Normal saline (sodium chloride 0.9%)IV (in the arm)
Treatment:
Drug: Nicotine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems